[ Price : $8.95]
FDA says an Arrow International recall of its Arrow-Trerotola percutaneous thrombolytic device is Class 1.[ Price : $8.95]
FDA grants Boehringer Ingelheim Pharmaceuticals a breakthrough therapy designation for its investigational therapy BI 1015550 and ...[ Price : $8.95]
Apricus Biosciences says it cant afford to do what FDA says is needed for a Vitaros NDA resubmission and it is shopping the U.S. r...[ Price : $8.95]
FDA releases an FDA-483 with seven observations from an inspection at Englewood, CO-based Denver Solutions outsourcing facility.[ Price : $8.95]
FDA approves a new Jardiance indication to reduce the risk of cardiovascular death and hospitalization for heart failure in adults...[ Price : $8.95]
FDA clears a Viz.ai 510(k) for the Viz Aneurysm module and its use on the Viz Intelligent Care Coordination Platform for detecting...[ Price : $8.95]
FDA extends its review of a United Therapeutics NDA resubmission for Tyvaso DPI (inhaled treprostinil) after receiving an informat...[ Price : $8.95]
Federal Register notice: FDA publishes a proposed rule to amend medical device current GMP requirements of the Quality System Regu...